These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29990471)

  • 1. Transdifferentiation of Melanoma Cells by the Reprogramming Factors Attenuates Malignant Nature In Vitro and In Vivo.
    Takaishi M; Sano S
    J Invest Dermatol; 2019 Jan; 139(1):254-257. PubMed ID: 29990471
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdifferentiation from the top.
    Nawy T
    Nat Methods; 2015 Aug; 12(8):701. PubMed ID: 26451422
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemical reprogramming and transdifferentiation.
    Xie X; Fu Y; Liu J
    Curr Opin Genet Dev; 2017 Oct; 46():104-113. PubMed ID: 28755566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Reprogramming: The Many Roads to Success.
    Aydin B; Mazzoni EO
    Annu Rev Cell Dev Biol; 2019 Oct; 35():433-452. PubMed ID: 31340126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
    Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J
    Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A marker for melanoma?
    Chande M
    Lancet; 2001 Aug; 358(9281):565. PubMed ID: 11520537
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular drivers of cellular metabolic reprogramming in melanoma.
    Abildgaard C; Guldberg P
    Trends Mol Med; 2015 Mar; 21(3):164-71. PubMed ID: 25618774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of NRAS and BRAF mutations in cutaneous melanoma.
    Rosso R; Romagosa Y; Kirsner RS
    J Invest Dermatol; 2009 Jun; 129(6):1318. PubMed ID: 19434085
    [No Abstract]   [Full Text] [Related]  

  • 12. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simpler twist of fate.
    Eisenstein M
    Nature; 2016 Jun; 534(7607):421-3. PubMed ID: 27306187
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct reprogramming with SOX factors: masters of cell fate.
    Julian LM; McDonald AC; Stanford WL
    Curr Opin Genet Dev; 2017 Oct; 46():24-36. PubMed ID: 28662445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards understanding transcriptional networks in cellular reprogramming.
    Firas J; Polo JM
    Curr Opin Genet Dev; 2017 Oct; 46():1-8. PubMed ID: 28646660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ups and downs of transcription factors in melanoma.
    Santiago-Walker A; Herlyn M
    J Natl Cancer Inst; 2010 Aug; 102(15):1103-4. PubMed ID: 20660367
    [No Abstract]   [Full Text] [Related]  

  • 17. Unraveling mysteries of the multifunctional protein SPARC.
    Fukunaga-Kalabis M; Herlyn M
    J Invest Dermatol; 2007 Nov; 127(11):2497-8. PubMed ID: 17934501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma.
    Miller AJ; Mihm MC
    N Engl J Med; 2006 Jul; 355(1):51-65. PubMed ID: 16822996
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
    Bosserhoff AK; Echtenacher B; Hein R; Buettner R
    Melanoma Res; 2001 Aug; 11(4):417-21. PubMed ID: 11479431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of human malignant melanoma clonal cell lines that secrete ectopic adrenocorticotropin.
    Orth DN
    Nat New Biol; 1973 Mar; 242(114):26-8. PubMed ID: 4348147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.